相关实验视频
Updated: Jun 11, 2025
07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.3K
上腺素自动注射器用于预防致命的过敏反应
Marcus Sim1, Vibha Sharma2,3, Karen Li1
1National Heart and Lung Institute, Imperial College London, London, UK.
概括
上腺素自注射器 (AAI) 可能无法有效地预防由于短暂的上腺素水平导致的致命过敏反应. 研究建议探索持续上腺素输送的替代方案,以改善严重过敏反应的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 过敏反应是一种严重的过敏反应,可影响多达5%的人口.
- 虽然过敏反应往往在没有持续的身体伤害的情况下得到解决,但可以导致严重的焦虑和降低生活质量.
- 过敏反应的致命结果,虽然很少见,但可以在社区中不可预测地发生.
研究的目的:
- 评估上腺素自注射器 (AAI) 在预防致命过敏反应方面的有效性.
- 分析来自动物和人类研究的数据,以及关于AAI疗效的流行病学证据.
- 确定当前AAI的潜在局限性,并探索替代治疗策略.
主要方法:
- 关于上腺素的体内动物和人体研究的综述.
- 对AAI处方率和致命过敏反应的流行病学数据的分析.
- 通过不同的途径提供上腺素的药理动力学和药理动力学评估.
主要成果:
- 静脉注射上腺素输注有效逆转过敏反应,需要持续剂量.
- 来自AAI的肌内上腺素可以达到暂时的血峰值水平,但可能是短暂且不可预测的.
- 流行病学数据显示,AAI处方增加和致命过敏反应率降低之间没有明确的联系.
结论:
- 由于持续上腺素度不足,目前的AAI可能对致命的过敏反应的影响有限.
- 药物对生活质量的有效性是可变的.
- 需要替代方法,可以安全地为过敏反应治疗提供持续的上腺素输液.
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
738
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
738
02:06Allergic Reactions
27.3K
Overview
27.3K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
2
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
2
01:30Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
235
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
235